Literature DB >> 23020677

Seven cysteine-deficient mutants depict the interplay between thermal and chemical stabilities of individual cysteine residues in mitogen-activated protein kinase c-Jun N-terminal kinase 1.

Tetsuko Nakaniwa1, Harumi Fukada, Tatsuya Inoue, Masaki Gouda, Ryoko Nakai, Yasuyuki Kirii, Motoyasu Adachi, Taro Tamada, Shin-Ichi Segawa, Ryota Kuroki, Toshiji Tada, Takayoshi Kinoshita.   

Abstract

Intracellular proteins can have free cysteines that may contribute to their structure, function, and stability; however, free cysteines can lead to chemical instabilities in solution because of oxidation-driven aggregation. The MAP kinase, c-Jun N-terminal kinase 1 (JNK1), possesses seven free cysteines and is an important drug target for autoimmune diseases, cancers, and apoptosis-related diseases. To characterize the role of cysteine residues in the structure, function, and stability of JNK1, we prepared and evaluated wild-type JNK1 and seven cysteine-deficient JNK1 proteins. The nonreduced sodium dodecyl sulfate-polyacrylamide gel electrophoresis experiments showed that the chemical stability of JNK1 increased as the number of cysteines decreased. The contribution of each cysteine residue to biological function and thermal stability was highly susceptible to the environment surrounding the particular cysteine mutation. The mutations of solvent-exposed cysteine to serine did not influence biological function and increased the thermal stability. The mutation of the accessible cysteine involved in the hydrophobic pocket did not affect biological function, although a moderate thermal destabilization was observed. Cysteines in the loosely assembled hydrophobic environment moderately contributed to thermal stability, and the mutations of these cysteines had a negligible effect on enzyme activity. The other cysteines are involved in the tightly filled hydrophobic core, and mutation of these residues was found to correlate with thermal stability and enzyme activity. These findings about the role of cysteine residues should allow us to obtain a stable JNK1 and thus promote the discovery of potent JNK1 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23020677     DOI: 10.1021/bi300918w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase A.

Authors:  Huawei Qiu; Denise M Honey; Jonathan S Kingsbury; Anna Park; Ekaterina Boudanova; Ronnie R Wei; Clark Q Pan; Tim Edmunds
Journal:  Protein Sci       Date:  2015-07-14       Impact factor: 6.725

2.  A Specific and Covalent JNK-1 Ligand Selected from an Encoded Self-Assembling Chemical Library.

Authors:  Gunther Zimmermann; Ulrike Rieder; Davor Bajic; Sara Vanetti; Apirat Chaikuad; Stefan Knapp; Jörg Scheuermann; Martin Mattarella; Dario Neri
Journal:  Chemistry       Date:  2017-05-30       Impact factor: 5.236

3.  Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine.

Authors:  Kawaljit Kaur; Jian Xiong; Nishant Sawant; Sanjeev Agarwal; John M Hickey; David A Holland; Tarit K Mukhopadhyay; Joseph R Brady; Neil C Dalvie; Mary Kate Tracey; Kerry R Love; J Christopher Love; David D Weis; Sangeeta B Joshi; David B Volkin
Journal:  J Pharm Sci       Date:  2020-12-03       Impact factor: 3.534

4.  Rational Design of the Soluble Variant of l-Pipecolic Acid Hydroxylase using the α-Helix Rule and the Hydropathy Contradiction Rule.

Authors:  Suguru Shinoda; Aoi Itakura; Haruka Sasano; Ryoma Miyake; Hiroshi Kawabata; Yasuhisa Asano
Journal:  ACS Omega       Date:  2022-08-11

5.  Proposing the Promiscuous Protein Structures in JNK1 and JNK3 for Virtual Screening in Pursuit of Potential Leads.

Authors:  Ananthasri Sailapathi; Gopinath Murugan; Kanagasabai Somarathinam; Seshan Gunalan; Rahul Jagadeesan; Niyaz Yoosuf; Sekar Kanagaraj; Gugan Kothandan
Journal:  ACS Omega       Date:  2020-02-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.